International Journal of Nanomedicine

Nanomedicine for Cancer and Autoimmune Immunotherapy

Immune-mediated diseases, including autoimmune disorders and cancer, represent major global health burdens arising from immune system dysfunction. Conventional therapies aim to suppress or activate immune responses, yet their lack of specificity often results in systemic toxicity, off-target effects, and limited therapeutic efficacy. Current immunotherapies often involve a trade-off between therapeutic efficacy and safety. Nanomedicine has emerged as a promising approach to address these challenges by enabling precise control over drug release, biodistribution, and immune cell targeting.